Saturday 17 October 2026
Export QSI’s income statement to Excel — free account
Quantum-Si Incorporated
QSI Healthcare Medical Devices
Quantum-Si Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, down 20.3% from fiscal 2024. In the quarter to June 2026, revenue fell 41.8%, EPS grew 31.3% and free cash flow grew 9.75%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.12
0.19
−14.50%
Follow QSI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 2 | — |
+8 more TTM periods Free account |
| (49.11%) | (46.38%) | (46.52%) | (52.44%) | ||
| (43.98%) | (42.85%) | (41.07%) | (47.06%) | ||
ROIC |
(100.92%) | (97.95%) | (126.60%) | (843.28%) | |
Return on Tangible Assets |
(83.46%) | (76.18%) | (61.04%) | (50.98%) | |
Average Days of Receivables |
12.96 | 40.01 | 779.00 | 619.59 | |
Free Cash Flow per Share |
(0.43) | (0.44) | (0.49) | (0.50) | |
Free Cash Flow |
(93.69) | (95.69) | (97.23) | (105.22) | |
Capital Expenditures |
(1.24) | (1.49) | (2.52) | (3.97) | |
| Other line items | |||||
Cash ROIC |
(32.09%) | (29.17%) | (25.38%) | (22.82%) | |
Accounts Receivable Turnover |
0.57 | 3.00 | 0.75 | 0.99 | |
Accounts Payable Turnover |
0.55 | 0.60 | 0.72 | 0.88 | |
Inventory Turnover |
0.35 | 0.34 | 0.35 | 0.40 | |
Average Days of Payables |
556.77 | 588.07 | 461.73 | 319.85 | |
Days of Inventory on Hand |
709.35 | 719.82 | 909.51 | 834.79 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3,435.51% | 2,944.33% | 2,206.86% | 1,882.31% | |
Selling, General and Administrative Expense of Revenue |
2,529.22% | 2,295.52% | 1,837.19% | 1,535.51% | |
Share Based Compensation of Revenue |
693.46% | 592.66% | 442.24% | 330.19% | |
Operating CF/Net income |
0.94 | 0.91 | 0.93 | 0.87 | |
Depreciation/Fixed assets |
(0.05) | (0.17) | (0.27) | (0.30) | |
Capex/Depreciation |
2.18 | 0.74 | 0.71 | 0.97 | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.02 | |
Operating CF per Share |
(0.42) | (0.44) | (0.48) | (0.48) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.02) | |
Capex to Sales |
0.77 | 0.80 | 1.03 | 1.25 |
Columns are period end dates